MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-03-2025
IDEXX Laboratories ROE Ratio 2011-2025 | IDXX
Annual ROE Ratio IDEXX Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.65 | 56.92 | 111.56 | 107.95 | 91.94 | 240.53 | -4083.52 | -488.73 | -205.19 | -228.68 | 154.7 | 36.24 | 28.02 | 29.98 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 240.53 | -4083.52 | -292.33 |
Quarterly ROE Ratio IDEXX Laboratories
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68.89 | 65.69 | 58.4 | 42.27 | 58.63 | 60.6 | 68.23 | 62.31 | 100.32 | 121.97 | 130.35 | 97.21 | 120.4 | 105.59 | 103.79 | 79.32 | 102.45 | 102.39 | 98.87 | 64.39 | 115.38 | 153.57 | 200.84 | 241.01 | -710.21 | -1751.78 | -2965.16 | -3963.32 | -3133.81 | -2283.88 | -1299.09 | -486.35 | -463.97 | -385.76 | -290.02 | -204.93 | -209.31 | -209.78 | -215.41 | -228.32 | -153.52 | -56.58 | 59.76 | 154.79 | 141.05 | 105.5 | 67.23 | 36.24 | 34.71 | 32.63 | 30.27 | 28.02 | 28.25 | 28.65 | 29.6 | 29.98 | 7.14 | 9.02 | 6.79 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 241.01 | -3963.32 | -267.1 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 17.27 | 1.8 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 15.82 | 0.44 % | $ 170 M |  China |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.55 | -4.63 % | $ 1.97 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 12.14 | 2.1 % | $ 344 M | Israel |
 |
DexCom
DXCM
|
26.18 | $ 65.83 | -1.69 % | $ 25.4 B | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 39.06 | 1.11 % | $ 1.08 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 101.64 | 0.14 % | $ 18.8 B | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 227.72 | 0.54 % | $ 166 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 27.0 | -0.52 % | $ 816 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 19.98 | -2.82 % | $ 1.07 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 101.67 | -3.4 % | $ 4.01 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
-62.78 | $ 3.3 | -7.82 % | $ 105 K | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 0.29 | -14.47 % | $ 8.51 M | USA |
 |
IQVIA Holdings
IQV
|
22.63 | $ 222.75 | 0.24 % | $ 40.4 B | USA |
 |
Guardant Health
GH
|
312.48 | $ 103.7 | 1.6 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 134.4 | -0.35 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 197.62 | 2.4 % | $ 10.2 B | USA |
 |
Quotient Limited
QTNT
|
312.05 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 410.02 | 1.15 % | $ 29.9 B | Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 183.96 | 0.79 % | $ 20.4 B | USA |
 |
NeoGenomics
NEO
|
-8.72 | $ 12.03 | 1.48 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 6.85 | -0.22 % | $ 1.49 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 7.63 | -2.8 % | $ 989 M | USA |
 |
Myriad Genetics
MYGN
|
-18.16 | $ 7.04 | -2.36 % | $ 638 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 262.89 | -0.48 % | $ 22.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 184.38 | -1.18 % | $ 15.2 B |  Irlanda |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 66.4 | -0.33 % | $ 4.59 B | USA |
 |
Agilent Technologies
A
|
22.45 | $ 140.3 | 0.46 % | $ 42.7 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.48 | -2.65 % | $ 5.7 M | USA |
 |
Bioventus
BVS
|
-90.0 | $ 7.49 | -0.86 % | $ 469 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Pacific Biosciences of California
PACB
|
-43.74 | $ 2.13 | 0.24 % | $ 540 M | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |